330 related articles for article (PubMed ID: 23099277)
1. Amino acids as promoieties in prodrug design and development.
Vig BS; Huttunen KM; Laine K; Rautio J
Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
3. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs: effective solutions for solubility, permeability and targeting challenges.
Hu L
IDrugs; 2004 Aug; 7(8):736-42. PubMed ID: 15334306
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of dendrimer prodrugs.
Kojima C
Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
[TBL] [Abstract][Full Text] [Related]
7. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
8. [Research of oral prodrugs: opportunities and challenges].
Cao F; Ping QN; Chen J
Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
[TBL] [Abstract][Full Text] [Related]
9. Prodrugs--from serendipity to rational design.
Huttunen KM; Raunio H; Rautio J
Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
[TBL] [Abstract][Full Text] [Related]
10. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
11. In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates.
Kim MK; Park KS; Yeo WS; Choo H; Chong Y
Bioorg Med Chem; 2009 Feb; 17(3):1164-71. PubMed ID: 19128975
[TBL] [Abstract][Full Text] [Related]
12. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
13. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
14. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
15. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Derived Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs.
Singh Y; Saklani S; Tantra T; Thareja S
Curr Top Med Chem; 2021; 21(24):2170-2183. PubMed ID: 34080965
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Conover CD; Greenwald RB; Pendri A; Shum KL
Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
[TBL] [Abstract][Full Text] [Related]
18. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
19. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs: a challenge for the drug development.
Zawilska JB; Wojcieszak J; Olejniczak AB
Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]